SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001537055-19-000004
Filing Date
2019-02-14
Accepted
2019-02-14 15:51:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 orexye18.txt SC 13G/A 25736
  Complete submission text file 0001537055-19-000004.txt   27209
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Subject) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-83422 | Film No.: 19605653
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 545 FIFTH AVE SUITE 1108 NEW YORK NY 10017
Business Address 545 FIFTH AVE SUITE 1108 NEW YORK NY 10017 212-425-9700
Telemetry Investments, L.L.C. (Filed by) CIK: 0001537055 (see all company filings)

IRS No.: 134081603
Type: SC 13G/A